Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.030 |
None |
1.000 |
3 |
1
|
2000 |
2013 |
Malignant tumor of colon
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
2969
|
688
|
0.030 |
None |
1.000 |
3 |
1
|
2004 |
2016 |
Childhood Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2527
|
98
|
0.030 |
None |
1.000 |
3 |
|
2015 |
2018 |
Colon Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
2832
|
275
|
0.030 |
None |
1.000 |
3 |
1
|
2004 |
2008 |
Hyperandrogenism
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
108
|
24
|
0.030 |
None |
1.000 |
3 |
1
|
2001 |
2004 |
Rheumatoid Arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
2723
|
2387
|
0.030 |
None |
1.000 |
3 |
1
|
2015 |
2018 |
Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3177
|
281
|
0.030 |
None |
1.000 |
3 |
|
2015 |
2018 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.500 |
None |
1.000 |
3 |
|
2012 |
2013 |
Steatohepatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1143
|
75
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2018 |
Obesity-Associated Insulin Resistance
|
disease |
|
Disease or Syndrome
|
36
|
|
0.020 |
None |
1.000 |
2 |
|
2001 |
2018 |
Mental deterioration
|
phenotype |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
508
|
121
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2019 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.320 |
None |
1.000 |
2 |
|
2005 |
2008 |
Adenocarcinoma of lung (disorder)
|
disease |
Neoplasms
|
Neoplastic Process
|
2438
|
563
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2018 |
Squamous cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2507
|
257
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
estrogen receptor-negative breast cancer
|
disease |
|
Neoplastic Process
|
356
|
40
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2011 |
Tauopathies
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
245
|
43
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2019 |
Anaplasia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
538
|
7
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
Arteriosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2006
|
267
|
0.020 |
None |
0.500 |
2 |
|
2011 |
2013 |
Precocious pubarche
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
30
|
11
|
0.020 |
None |
1.000 |
2 |
1
|
2001 |
2002 |
Atherosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2044
|
281
|
0.020 |
None |
0.500 |
2 |
|
2011 |
2013 |
Ataxia Telangiectasia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
384
|
698
|
0.020 |
None |
1.000 |
2 |
|
1989 |
1990 |
Adult Acute Lymphocytic Leukemia
|
disease |
|
Neoplastic Process
|
860
|
154
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2019 |
ovarian neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2542
|
757
|
0.020 |
None |
1.000 |
2 |
|
2007 |
2012 |
Sleep Apnea, Obstructive
|
disease |
Respiratory Tract Diseases; Nervous System Diseases
|
Disease or Syndrome
|
480
|
105
|
0.020 |
None |
0.500 |
2 |
1
|
2006 |
2016 |
Insulin resistance syndrome
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
62
|
15
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2004 |